Profil
Erin S.
Cox worked as the Director of Investor Relations at Evoq Properties, Inc. She was the Head of Investor Relations at Sarepta Therapeutics, Inc. from 2012 to 2014.
She also worked as the Head of Investor and Media Relations at Omeros Corp.
and as the Head of Investor Relations and Media Inquiries at PhaseRx, Inc. from 2016 to 2017.
Ms. Cox received her undergraduate degree from the University of Washington in 1997.
Anciens postes connus de Erin S. Cox
| Sociétés | Poste | Fin |
|---|---|---|
| VERASTEM, INC. | Public Communications Contact | 01/06/2019 |
| PHASERX, INC. | Investor Relations Contact | 01/10/2017 |
| SAREPTA THERAPEUTICS, INC. | Investor Relations Contact | 01/05/2014 |
| OMEROS CORPORATION | Investor Relations Contact | - |
| MERUELO M | Public Communications Contact | - |
Formation de Erin S. Cox
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Omeros Corp.
Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
EVOQ Properties, Inc.
EVOQ Properties, Inc. Real Estate DevelopmentFinance Develops, redevelops and owns commercial & residential properties | Finance |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PhaseRx, Inc.
PhaseRx, Inc. Pharmaceuticals: MajorHealth Technology Manufactures enzyme replacement therapies | Health Technology |
Verastem, Inc.
Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs | Health Technology |
















